Welcome to LookChem.com Sign In|Join Free
  • or
Carbopenem Intermediate is a critical chemical intermediate in the synthesis of carbopenem antibiotics, a class of broad-spectrum antibiotics. It plays a pivotal role in the pharmaceutical industry for the manufacturing of these drugs, which are used to treat a variety of bacterial infections. As a key building block in the production of important antibiotics, it is essential for combating a wide range of bacterial pathogens. The production and use of Carbopenem Intermediate are strictly regulated to ensure the quality and safety of the resulting pharmaceutical products.

124044-13-9

Post Buying Request

124044-13-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

124044-13-9 Usage

Uses

Used in Pharmaceutical Industry:
Carbopenem Intermediate is used as a key component in the synthesis of carbopenem antibiotics for the treatment of various bacterial infections. Its role in the manufacturing process is crucial, as it contributes to the development of effective and safe pharmaceutical products.
Used in Antibacterial Drug Development:
Carbopenem Intermediate is utilized as a fundamental building block in the creation of new and innovative antibiotics. Its presence in the synthesis process allows for the development of drugs that can target and combat a broad spectrum of bacterial pathogens, providing a valuable resource in the ongoing fight against antibiotic-resistant bacteria.
Used in Quality Assurance and Regulatory Compliance:
In the production of carbopenem antibiotics, Carbopenem Intermediate is used to ensure the quality and safety of the final pharmaceutical products. Its tightly regulated production and use help maintain industry standards and comply with regulatory requirements, safeguarding the health and well-being of patients who rely on these antibiotics for treatment.

Check Digit Verification of cas no

The CAS Registry Mumber 124044-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,0,4 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 124044-13:
(8*1)+(7*2)+(6*4)+(5*0)+(4*4)+(3*4)+(2*1)+(1*3)=79
79 % 10 = 9
So 124044-13-9 is a valid CAS Registry Number.

124044-13-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate

1.2 Other means of identification

Product number -
Other names methyl (2S,3R)-2-benzamidomethyl-3-hydroxybutanoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:124044-13-9 SDS

124044-13-9Synthetic route

methyl 2-[(N-benzoylamino)methyl]-3-oxobutyrate
129994-60-1

methyl 2-[(N-benzoylamino)methyl]-3-oxobutyrate

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate
124044-13-9

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate

Conditions
ConditionsYield
In hexane; dichloromethane; nitrogen; ethyl acetate90%
In hexane; dichloromethane; ethyl acetate87%
With hydrogen; (R)-3,5-t-Bu2-binap-RuI2 In methanol; dichloromethane at 50 - 60℃; under 38000 Torr; for 40h; Product distribution; other cationic binap-ruthenium(II) catalysts, var. solvents, reaction time, substrate/catalyst ratio; diastereoselectivity and enantioselectivity of the reduction;55%
methyl 2-[(N-benzoylamino)methyl]-3-oxobutyrate
129994-60-1

methyl 2-[(N-benzoylamino)methyl]-3-oxobutyrate

A

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate
124044-13-9

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate

B

(2R,3S)-methyl 2-(benzamidomethyl)-3-hydroxybutanoate
129994-65-6

(2R,3S)-methyl 2-(benzamidomethyl)-3-hydroxybutanoate

C

anti-(2R,3R)-Methyl 2-(benzamidomethyl)-3-hydroxybutanoate
135138-76-0

anti-(2R,3R)-Methyl 2-(benzamidomethyl)-3-hydroxybutanoate

D

(2S,3S)-methyl-2-benzamido-methyl-3-hydroxybutyrate
145588-28-9

(2S,3S)-methyl-2-benzamido-methyl-3-hydroxybutyrate

Conditions
ConditionsYield
With hydrogen; (p-cymene)>I In methanol at 65℃; under 41040 Torr; for 20h; Product distribution; Ru(II)-asymmetric hydrogenation, diastereoselectivity and enantioselectivity, effect of solvents;
With hydrogen; <((R)-(1,1'-binaphthyl-2,2'-diyl)bis(diphenylphosphine))RuCl2>2NEt3 at 50℃; under 76000.1 Torr; for 20h; Yields of byproduct given. Title compound not separated from byproducts;
methyl 2-[(N-benzoylamino)methyl]-3-oxobutyrate
129994-60-1

methyl 2-[(N-benzoylamino)methyl]-3-oxobutyrate

A

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate
124044-13-9

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate

B

anti-(2R,3R)-Methyl 2-(benzamidomethyl)-3-hydroxybutanoate
135138-76-0

anti-(2R,3R)-Methyl 2-(benzamidomethyl)-3-hydroxybutanoate

Conditions
ConditionsYield
With hydrogen; I In methanol at 50℃; under 38000 Torr; for 20h; Product distribution; other: catalysts, solvents, time, pressure;
With hydrogen; I In methanol; dichloromethane at 65℃; under 41040 Torr; for 21h; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
With hydrogen; I In methanol; dichloromethane at 50 - 60℃; under 38000 Torr; for 40h; Yield given. Yields of byproduct given;
With hydrogen; I In methanol at 50℃; under 38000 Torr; for 20h; Yield given. Yields of byproduct given;
methyl 2-[(N-benzoylamino)methyl]-3-oxobutyrate
129994-60-1

methyl 2-[(N-benzoylamino)methyl]-3-oxobutyrate

A

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate
124044-13-9

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate

B

(2R,3S)-methyl 2-(benzamidomethyl)-3-hydroxybutanoate
129994-65-6

(2R,3S)-methyl 2-(benzamidomethyl)-3-hydroxybutanoate

C

anti-(2R,3R)-Methyl 2-(benzamidomethyl)-3-hydroxybutanoate
135138-76-0

anti-(2R,3R)-Methyl 2-(benzamidomethyl)-3-hydroxybutanoate

Conditions
ConditionsYield
With hydrogen; <((R)-(1,1'-binaphthyl-2,2'-diyl)bis(diphenylphosphine))RuCl2>2NEt3 at 50℃; under 76000.1 Torr; for 20h; Yields of byproduct given. Title compound not separated from byproducts;
(2S)-methyl-2-benzamido-methyl-3-oxobutanoate

(2S)-methyl-2-benzamido-methyl-3-oxobutanoate

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate
124044-13-9

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate

Conditions
ConditionsYield
With glucose dehydrogenase; alpha-D-glucopyranose; BgADH2 enzyme; nicotinamide adenine dinucleotide phosphate In water; toluene at 35℃; for 8h; pH=6.5; Reagent/catalyst; Enzymatic reaction; enantioselective reaction;n/a
methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate
124044-13-9

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate

(2S,3R)-2-aminomethyl-3-hydroxybutanoic acid hydrochloride
129994-66-7

(2S,3R)-2-aminomethyl-3-hydroxybutanoic acid hydrochloride

Conditions
ConditionsYield
With hydrogenchloride93%
methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate
124044-13-9

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate

benzoic acid
65-85-0

benzoic acid

Conditions
ConditionsYield
With hydrogenchloride93%
methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate
124044-13-9

methyl (2S,3R)-2-[(N-benzoylamino)-methyl]-3-hydroxybutyrate

(2S)-3-amino-2-((1R)-1-hydroxyethyl)propionic acid
120236-27-3

(2S)-3-amino-2-((1R)-1-hydroxyethyl)propionic acid

Conditions
ConditionsYield
With triethylamine In 12N-hydrochloric acid; toluene; acetonitrile80%

124044-13-9Relevant academic research and scientific papers

Preparation method of 4AA

-

Paragraph 0016; 0018; 0021; 0024, (2021/07/28)

The invention discloses a preparation method of 4AA. The preparation method comprises the following steps: S1, preparing a first intermediate from benzamide and a formaldehyde aqueous solution; S2, preparing a second intermediate from the first intermediate, thionyl chloride, toluene and n-heptane; S3, preparing a third intermediate from the second intermediate, methyl acetoacetate, sodium methoxide, toluene, diluted hydrochloric acid and isopropanol; S4, preparing a fourth intermediate from the third intermediate, reductase, ethyl acetate, saturated sodium bicarbonate and saturated salt water; S5, preparing a fifth intermediate from the fourth intermediate, imidazole, TBSCL and methylbenzene; S6, preparing a sixth intermediate from the fifth intermediate, ethanolamine, methanol and n-heptane; S7, preparing a seventh intermediate by using the sixth intermediate, a Grignard reagent and n-heptane; and S8, preparing 4AA from the seventh intermediate, ruthenium trichloride, potassium acetate, ethyl acetate, acetic acid and a peracetic acid solution.

Preparation method of (2S,3R)-2-acylaminomethyl-3-hydroxybutyrate

-

Paragraph 0047-0063; 0070-0075, (2020/08/22)

The invention provides a preparation method of (2S,3R)-2-acylaminomethyl-3-hydroxybutyrate, which adopts a catalytic system composed of a bivalent ruthenium complex and a C3*-Tunephos series C2 axisymmetric bidentate phosphine ligand to carry out an asymmetric reduction reaction in a hydrogen atmosphere. The preparation method provided by the invention has the characteristics of high atom economy,greenness, no pollution, single selectivity, high production efficiency and the like, and the catalyst is easy to synthesize and low in production cost and has a good industrial application prospect.

Asymmetric synthesis of optically active methyl-2-benzamido-methyl-3-hydroxy-butyrate by robust short-chain alcohol dehydrogenases from Burkholderia gladioli

Chen, Xiang,Liu, Zhi-Qiang,Huang, Jian-Feng,Lin, Chao-Ping,Zheng, Yu-Guo

supporting information, p. 12328 - 12331 (2015/07/27)

Three short-chain alcohol dehydrogenases from Burkholderia gladioli were discovered for their great potential in the dynamic kinetic asymmetric transformation of methyl 2-benzamido-methyl-3-oxobutanoate, and their screening against varied organic solvents and substrates. This is the first report of recombinant enzymes capable of achieving this reaction with the highest enantio- and diastereo-selectivity.

Process for preparing optically active oxazolidinone derivative

-

, (2008/06/13)

Disclosed is a process for preparing an optically active oxazolidinone derivative comprising allowing hydrazine to react on an optically active ester having a hydroxyl group at the 3-position which is represented by formula (II): wherein R1represents a lower alkyl group having 1 to 4 carbon atoms, a phenyl group, a methoxymethyl group, a benzyloxymethyl group, a benzyloxycarbonylaminomethyl group which may have a substituent or substituents on the benzene ring thereof, an acylaminomethyl group having 3 to 10 carbon atoms, or an alkyloxycarbonylaminomethyl group having 3 to 6 carbon atoms; R2and R3, which may be the same or different, each represent a hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms, a phenyl group, an acetylaminomethyl group, a benzoylaminomethyl group, or a benzyl group; and * indicates an asymmetric carbon atom, and subjecting the resulting hydrazide to Curtius rearrangement.

New Chiral Diphosphine Ligands Designed to Have a Narrow Dihedral Angle in the Biaryl Backbone

Saito, Takao,Yokozawa, Tohru,Ishizaki, Takero,Moroi, Takashi,Sayo, Noboru,Miura, Takashi,Kumobayashi, Hidenori

, p. 264 - 267 (2007/10/03)

A series of novel optically active diphosphine ligands, (4,4′-bi-1,3-benzodioxole)-5,5′-diylbis(diarylphosphine)s (6), which are called SEGPHOS, has been designed and synthesized with dihedral angles in the Ru complexes being less than that in the corresponding BINAP-Ru complex. The stereorecognition abilities of SEGPHOS-Ru complex catalysts in the asymmetric catalytic hydrogenation of a wide variety of carbonyl compounds are superior to those observed with BINAP-Ru complex catalysts.

Method of preparing a derivative of optically active azetidin-2-one

-

, (2008/06/13)

To prepare the compound (1'R,3S)-3-(1'-tri-substituted silyloxyethyl)azetidin-2-one, (2S,3R)-2-aminomethyl-3-hydroxybutyric acid is reacted with an alcohol in the presence of at least one compound chosen from the group consisting of thionyl chloride, hydrogen chloride and p-toluene sulfonic acid, thereby obtaining a salt of the corresponding ester. The salt is reacted with a tri-substituted silane in the presence of a metallic catalyst, thereby protecting the hydroxy group of the ester and then reacted with a base, thereby obtaining an ester of (2S,3R)-2-aminomethyl-3-(tri-substituted silyloxy)butyric acid. Subsequently, the ester is transformed into lactam in the presence of a Grignard reagent or a metal amide, thereby obtaining (1'R,3S)-3-(1'-tri-substituted silyloxyethyl)azetidin-2-one. This compound provides a useful base for preparing β-lactam type antimicrobial agents such as carbapenem type agents.

Cationic BINAP-Ru(II) Halide Complexes: Highly Efficient Catalysts for Stereoselective Asymmetric Hydrogenation of α- and β-Functionalized Ketones

Mashima, Kazushi,Kusano, Koh-hei,Sato, Naomasa,Matsumura, Yoh-ichi,Nozaki, Kyoko,et al.

, p. 3064 - 3076 (2007/10/02)

Cationic ruthenium-BINAP complexes 5, 7, and 10 of the formula Y, where X = Cl, Br, I; Y = Cl, Br, I, BF4, B(C6H5)4; arene = benzene, p-cymene, ethyl benzoate, and their enantiomers have been prepared by the reaction of arene-ruthenium halide complexes 4, 6, and 9 with (S)-BINAP or (R)-BINAP.Structures of the complexes were established by spectroscopy, conductivity, and a single-crystal X-ray analysis (5d: orthorhombic, P21212; a=20.141(2) Angstroem, b=18.504(1) Angstroem, c=12.241(1) Angstroem, V=4562.0(7) Angstroem3, Z=4, R=0.078 for unique 4177 reflections).BINAP derivatives with various substituents at the para and meta positions of four phenyl rings on phosphorus atoms and their cationic Ru(II) complexes have also been synthesized.These BINAP-Ru(II) complexes have been used as catalysts for the asymmetric hydrogenation of various unsaturated organic compounds such as α- and β-keto esters, allylic alcohols, and α,β-unsaturated carboxylic acids in excellent diastereo- and/or enantioselectivities.Catalytic activities and stereoselectivities depend highly on reaction conditions such as solvent, temperature, and additives.Variation of halogen ligands bound to ruthenium atom and substituents on four phenyl rings of BINAP also have exerted remarkable effects on the efficiency of the catalysis.Asymmetric hydrogenation of methyl (+/-)-2-(benzamidomethyl)-3-oxobutanoate catalyzed by the species derived from 9c and 3,5-(t-Bu)2-BINAP afforded the corresponding syn-(2S,3R)-17 in 98percent de and 99percent ee.

Synthesis of Partially Hydrogenated 2,2'-Bis(diphenylphosphenyl)-1,1'-binaphthyl (BINAP) Ligands and Their Application to Catalytic Asymmetric Hydrogenation

Zhang, Xiaoyong,Mashima, Kazushi,Koyano, Kinko,Sayo, Noboru,Kumobayashi, Hidenori,et al.

, p. 2309 - 2322 (2007/10/02)

Three pairs of new axially dissymmetric bisphosphane ligands, (R)-(-)- and (S)-(+)-2,2'-bis(dicyclohexylphosphanyl)-1,1'-binaphthyl , (R)-(+)- and (S)-(-)-2,2'-bis(diphenylphosphanyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl and (R)-(-)- and (S)-(+)-2,2'-bis(dicyclohexylphosphanyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl , have been synthesized.The absolute configurations of the isomers 2 were determined by single-crystal X-ray diffraction of the linear 1:1 polymeric complex of (S)-(+)-2,2'-bis(dicyclohexylphosphinoyl)-1,1'-binaphthyl and (2R,3R)-(-)-di-O-benzoyltartaric acid , and those of the isomers 3 and 4 were established on the basis of CD spectra of the phosphanes and their bisoxides.X-Ray crystallographic studies of two cationic RhI complexes, (cod)>ClO4 and (cod)>ClO4 , revealed that complex (S)-17 possesses a dissymmetric structure, while complex (S)-18 has a pseudo-C2-symmetry and shows a significantly large dihedral angle between the two phenyl rings .The potentiality of ligand 3 for asymmetric catalysis was demonstrated in RuII-catalysed stereoselective hydrogenations of methyl 2-(benzamidomethyl)-3-oxobutanoate (21, in up to 92percent d.e. and 99percent e.e.) and geraniol (22, in 98percent optical purity).

Ruthenium catalyzed process for preparing 4-acetoxyazetidinones

-

, (2008/06/13)

A simplified process for preparing 4-acetoxyazetidinones of formula (I): STR1 wherein Z is a hydrogen atom, a lower alkyl group or a hydroxyethyl group which may or may not be protected is disclosed. According to the invention, azetidinones of formula (II): STR2 wherein Z has the same meaning as defined above and Y is a hydrogen atom or a carboxyl group is reacted with acetic acid and an oxidizing agent in the presence of a ruthenium compound represented by the formula [Ru(B)2 (L)]m wherein B is Cl, Br or l, m is a positive integer, and L is 1,5-cyclooctadiene, norbornadiene, cycloheptatriene, cyclooctatetraene or benzene which may or may not have a lower alkyl group as a substituent, as a catalyst.

Process for preparing optically active 3-hydroxybutanoic acid

-

, (2008/06/13)

A process for preparing an optically active 3-hydroxybutanoic acid represented by formula (I): STR1 wherein: R1 represents a protective group of carboxylic acid, and R2 represents a hydrogen atom; a lower alkyl group which may be substituted with a halogen atom; a lower alkoxy group; a phenyl group which may be substituted with a lower alkyl group or a lower alkoxy group; or a benzyloxy group which may be substituted with a lower alkyl group or a lower alkoxy group, is disclosed, comprising asymmetrically hydrogenating a 3-oxobutanoic acid ester represented by formula (II): STR2 wherein R1 and R2 are as defined above, in the presence of a ruthenium-optically active phosphine complex as a catalyst. The compound of formula (I) which is useful for synthesizing a 4-acetoxyazetidin-2-one derivative, a useful intermediate for obtaining penem antibiotics, can be prepared economically.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 124044-13-9